CEO Serge Saxonov, PhD, says provider of single cell, spatial, and in situ instruments expects to see benefits from sales ...

In a report released today, Michael Ryskin from Bank of America Securities maintained a Hold rating on 10x Genomics (TXG – Research Report).

10x Genomics excels in single-cell and spatial technologies but faces significant challenges. Despite an EPS beat, revenue fell 1% due to sales disruption and competitive pricing. The company's ...

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell ...

The Saint Louis University Genomics Core Facility offers primarily single cell genomics and bioinformatics services to both internal and external users. The goal of the Core is to make genomics-based ...

Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, has been gaining from its continued product development. The optimism, led by decent 2024 preliminary results and restructuring ...

“We are confident the work we’ve done throughout 2024 sets us up well for the future and better positions us to deliver on the full promise of single cell and spatial biology.” J.P. Morgan Healthcare ...